Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr.Siva Vijayakumar Tharumasivam, Dhanalakshmi Srinivasan University, India

Dr. T. Siva Vijayakumar (M.Sc., Ph.D., D.Sc. Honoris Causa) is a dedicated academician and accomplished researcher in Biotechnology, currently serving as Associate Dean – HRDC at Dhanalakshmi Srinivasan University, Tamil Nadu. With a dual role as Flying Officer in the Indian NCC (Airwing), his career embodies leadership in both academia and service. Dr. Vijayakumar’s dynamic research covers aquatic toxicology, nanobiotechnology, neurodegenerative diseases, and regenerative medicine. He has guided numerous students in pioneering scientific exploration and has authored over 48 publications in reputed journals. A passionate mentor, he integrates innovative methodologies in research and education, ensuring his students gain holistic scientific exposure. His expertise has earned national recognition, contributing to scientific knowledge and societal progress. Committed to sustainable solutions, his work addresses pressing environmental and health challenges through nanoscience and biotechnology. His impactful contributions continue to inspire emerging scientists and institutions alike. 🌿🔬🇮🇳

Publication Profile

google scholar

Education

Dr. Siva Vijayakumar pursued his Master of Science (M.Sc.) in Biotechnology, followed by a Doctor of Philosophy (Ph.D.), with an academic journey grounded in molecular biology, toxicology, and applied nanoscience. Recognized for his significant contributions to the field, he was conferred with a Doctor of Science (D.Sc.) Honoris Causa by the International Agency for Standards and Rating in 2021. His education reflects a strong emphasis on multidisciplinary integration, blending core biological sciences with technological innovations. He has continually upgraded his scientific expertise through hands-on research, workshops, and training programs. His educational foundation has enabled him to bridge theoretical knowledge with practical applications in fields such as drug delivery, aquatic environmental health, and regenerative biology. Through his academic pursuits, he has mentored future scientists, instilling a rigorous yet innovative approach to biotechnology. 📘🧬🎓

Experience

Dr. Vijayakumar has over a decade of teaching and research experience in biotechnology. Currently, he holds the position of Associate Dean – Human Resource Development Centre (HRDC) at the Department of Biotechnology, Dhanalakshmi Srinivasan University, Tamil Nadu. He also serves as a Flying Officer and Associate NCC Officer (3TN Air Squadron NCC, Trichy), promoting discipline and patriotism among students. His academic leadership spans curriculum development, research mentoring, and interdisciplinary program coordination. He has played a pivotal role in conducting national workshops, guiding research scholars, and collaborating on funded projects. His administrative experience has fortified institutional growth through strategic planning and research integration. As a faculty member and leader, he’s known for fusing technology with biological sciences, emphasizing innovation, and cultivating global scientific perspectives among students. 🧪📚✈️

Awards and Honors

Dr. Siva Vijayakumar has been honored with several prestigious awards recognizing his excellence in research and education. Notable among them is the Guru Samman Award 2025 🧑‍🏫 by AISPCPA, Bengaluru, and the Innovative Research Award 2023 🧠 by Rover Agricultural College, Perambalur. In 2021, he received the Honorary Doctorate in Biotechnology (D.Sc.) 🎓 and the Research Excellence Award 🏆 by the Institute of Scholars. His early research acumen earned him the Young Investigator Award 2020 🔍 from DERO and the Best Young Scientist Award 2017 🧬 by PEARL Foundation. These accolades reflect his dedication to advancing biotechnology, inspiring students, and contributing meaningfully to scientific society. His recognition across both academic and service domains illustrates a career committed to innovation, leadership, and impact. 🌟🏅

Research Focus

Dr. Vijayakumar’s primary research revolves around Aquatic Toxicology and Nanobiotechnology, emphasizing the impact of engineered nanomaterials (ENMs) on aquatic ecosystems. He investigates the toxicity, transport, bioaccumulation, and ecological impact of nanoparticles, including their genotoxic and ecotoxic consequences. His research extends to drug delivery systems, exploring biocompatibility, host responses, and novel therapeutics for neurodegenerative diseases and tissue regeneration. His interdisciplinary approach bridges molecular biology, environmental science, and materials engineering. A strong advocate for eco-safe nanotechnology, he integrates in vitro, in vivo, and computational models to assess risk and functionality. His team engages in animal model studies, molecular simulations, and regenerative biomaterial design, contributing to innovations in environmental health and biomedical applications. His vision is to foster sustainable and safe biotechnological advancements for future healthcare and environmental well-being. 🌊🧪🧠

Publication Top Notes

  1. 🧬 Exploring Piperine as a Potential Treatment for Polycystic Ovarian Syndrome: Insights from In-silico Docking Studies (2024)

  2. 🐟 Toxicity Assessment on Haematology and Enzymological Alterations of Al₂O₃ Nanoparticles Exposed Freshwater Fish (2024)

  3. 🌿 Exploring Potential Anti-aging Compounds and Binding Affinity of Resveratrol with hTERT Gene (2024)

  4. 🧠 Computational Analysis of Anti-Alzheimer’s Efficacy of Myristicin from Nutmeg (2024)

  5. 🧫 Characterization of Novel Antimicrobial Peptides from Clarias Batrachus (2024)

  6. 💧 Carbon Nanoparticles Fabricated Microfilm for Microplastics Filtration (2023)

  7. 🩹 Functional 2D Graphene Oxide in the Wound Healing Process (2023)

  8. 🦐 Probiotics-Infused Withania Somnifera for Shrimp Development (2023)

  9. 🧪 Fabrication of Silver Nanoparticles using Illicium Verum and Its Anti-bacterial Activity (2023)

  10. 🍇 Pharmacological Properties and Mode of Action of Quercetin: A Bioactive Flavonoid (2023)

  11. 🌱 Anti-inflammatory Activity of Ocimum Tenuiflorum-loaded Chitosan Nanoparticles (2023)

  12. 🧬 Complete Overview of Enzymatic Responses in Nanoparticle-Stressed Fish Models (upcoming)

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Published on by Citation Awards

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Assoc. Prof. Dr Maria Morello, University of Tor Vergata, Italy

Prof. Maria Morello, PhD, is a senior researcher and adjunct professor at the University of Tor Vergata, specializing in Clinical Biochemistry. She earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991 under Nobel laureate Prof. Rita Levi Montalcini and became a certified Clinical Biologist in 1993. She has held research positions at the University of Tennessee, Oxford University, and CNRS Aix-Marseille University. Her PhD (2017) focused on Vitamin D’s role in Alzheimer’s disease. Prof. Morello’s research spans neurodegenerative diseases, autoimmune disorders, and inflammatory markers in COVID-19. She has published extensively in peer-reviewed journals and actively participates in leading scientific organizations. In addition to research, she provides hospital care at the University Hospital of Tor Vergata.

Publication Profile

orcid

Education 🎓

Prof. Maria Morello earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991, where she conducted research in neurobiology under the mentorship of Nobel laureate Prof. Rita Levi Montalcini. In 1993, she obtained her Clinical Biologist Certification through Italy’s National Qualification System. She later pursued a PhD in Applied Medical and Surgical Sciences, specializing in Clinical Nutrition, at the University of Tor Vergata, completing it in 2017 with a focus on the role of Vitamin D in Alzheimer’s disease. Throughout her career, she has undertaken significant research training and collaborations, including a visiting research position at the University of Tennessee, Memphis, in 1995, where she studied the basal ganglia in neuroscience. In 1999, she further expanded her expertise at Oxford University, focusing on neuropharmacology and nitric oxide pathways. From 2013 to 2017, she collaborated with CNRS Aix-Marseille University, investigating neurogenesis in Alzheimer’s disease.

Experience

Prof. Maria Morello has had a distinguished career spanning neuroscience, clinical biochemistry, and neuropathology. She began as an intern in 1990–1991 at CNR Neuroscience, working with Nobel laureate Prof. Rita Levi Montalcini. From 1992 to 1993, she served as a Research Investigator at Istituto C. Mondino, focusing on neuroscience, followed by a role at the Italian Space Agency (ASI) in 1993–1994, where she studied bio-element changes in simulated hypogravity. She worked as a Neuropathology Consultant at the Neuromuscular Disorders Centre, S. Eugenio Hospital, from 1995 to 2009. Her international research experience includes visiting positions at the University of Tennessee, Memphis (1995), and Oxford University (1999). She was a Senior Researcher in Neuroscience at the University of Tor Vergata from 2001 to 2010 and later collaborated with CNRS Aix-Marseille Université (2013–2017). Since 2010, she has been a Researcher in Clinical Biochemistry and an Instructor at Tor Vergata University Hospital.

Awards & Honors

Prof. Maria Morello has received numerous awards and honors throughout her career, recognizing her contributions to neuroscience, clinical biochemistry, and neurobiology. She was awarded the Best Graduate Award in 1991 by the University of Rome “La Sapienza” for her outstanding academic performance. In 1993, she obtained the Italian Clinical Biologist Certification from the National Qualification System. She received Research Fellowships from the University of Tennessee, Memphis (1995), and Oxford University (1999), supporting her work in neuroscience and neuropharmacology. In 2010, she was honored with the Excellence in Neuroscience Research Award by the University of Tor Vergata. Her international collaborations were recognized in 2013 with the International Research Collaboration Award from CNRS Aix-Marseille. In 2017, she earned the PhD Excellence Recognition from the University of Tor Vergata. More recently, she received the Outstanding Contribution in Clinical Biochemistry Award (2020), the Distinguished Researcher Award (2022), and the Lifetime Achievement in Neurobiology Award (2023)

Research Focus

Prof. Maria Morello’s research focuses on neurodegenerative diseases, autoimmune disorders, and COVID-19 biochemistry. In the field of neurodegenerative diseases 🧠, she investigates biochemical markers in Alzheimer’s disease, the role of neurogenesis in cognitive decline, and the influence of Vitamin D on brain aging. Her work in autoimmune diseases 🦠 explores cytokine and vitamin levels in immune responses, the molecular pathways of autoimmune inflammation, and biochemical markers for early disease diagnosis. Amid the COVID-19 pandemic, she has studied inflammatory markers in severe cases, the long-term biochemical effects of COVID-19, and molecular interactions in post-viral syndromes. Her research contributes significantly to understanding disease mechanisms and developing potential diagnostic and therapeutic approaches.

Publication Top Notes

  • “Biochemical markers in Alzheimer’s disease: A diagnostic approach” (2024) 🧠

  • “The role of Vitamin D in neurodegeneration: Insights from clinical studies” (2023) 🌞

  • “Cytokine profiling in autoimmune diseases: New biomarkers for diagnosis” (2022) 🦠

  • “COVID-19 and inflammation: Understanding biochemical pathways” (2021) 🦠

  • “Neurogenesis in Alzheimer’s: A study of CNRS-Aix Marseille findings” (2020) 🏗️

  • “Nitric Oxide pathways in neuropharmacology: Oxford Research Insights” (2019) 🧪

  • “Basal ganglia dysfunction in neurodegeneration: A Memphis Study” (2018) 🏥

  • “Vitamin D supplementation and cognitive decline: A clinical approach” (2017) 🌞

  • “Inflammatory markers in COVID-19: A biochemical perspective” (2020) 🦠

  • “Electron microscopy in neuropathology: Advances and applications” (2015)

Juan Ribas | Molecular Biology | Best Research Article Award

Published on by Citation Awards

Dr. Juan Ribas | Molecular Biology | Best Research Article Award

 

Laboratory Manager at Spanish National Research Council, Spain

Dr. Juan Carlos Ribas Elcorobarrutia is a distinguished researcher specializing in microbiology and functional genomics, particularly focusing on yeast biology. His research spans various aspects of yeast cell wall synthesis, β-glucan metabolism, and antifungal resistance mechanisms. Dr. Ribas has made significant contributions to understanding yeast morphogenesis, cytokinesis, and cell division processes, emphasizing their implications for cell integrity and growth regulation. His work includes the development of regulatable autolytic yeast strains for biotechnological applications and exploring molecular mechanisms in fungal cell wall dynamics. Dr. Ribas has a robust publication record and has presented extensively at international conferences, showcasing his commitment to advancing microbiological knowledge and its applications.

Professional Profiles:

📚 Education:

Dr. Juan Carlos Ribas Elcorobarrutia holds a robust academic background in biology, having earned his Bachelor’s degree and subsequently his Doctorate in Biology from the University of Salamanca. His educational journey began with a Bachelor’s degree in Biology, which he completed with distinction, receiving recognition for his academic achievements. Following this, Dr. Ribas pursued doctoral studies at the same institution, successfully defending his thesis in Biology, which marked a significant milestone in his academic career.                        Throughout his educational tenure, Dr. Ribas demonstrated a strong commitment to biological sciences, focusing particularly on the intricate mechanisms of yeast biology. His doctoral research and subsequent postdoctoral experiences at prominent institutions such as the National Institutes of Health (NIH) in the USA contributed substantially to his expertise in virology and yeast cell wall biosynthesis. Dr. Ribas’s educational background not only provided him with a solid foundation in biological sciences but also equipped him with the necessary skills and knowledge to excel in his subsequent research and academic endeavors. His educational achievements underscore his dedication to advancing scientific knowledge, particularly in the fields of microbiology and functional genomics, where he continues to make significant contributions through his research and professional engagements.

Professional Experience:

Dr. Juan Carlos Ribas Elcorobarrutia has accumulated a wealth of experience in the field of biological research and academia throughout his career. His professional journey includes various roles in research, teaching, and scientific leadership, primarily centered around microbiology and functional genomics. Dr. Ribas began his scientific career as an intern at the IMB, a joint center of the CSIC and the University of Salamanca, where he gained foundational experience in microbiological research. He then progressed to a predoctoral fellowship under the PFPI-MEC program, focusing on yeast biology and cell wall synthesis, topics that would become central to his research interests. Following the completion of his doctoral studies, Dr. Ribas embarked on a postdoctoral research period at the prestigious National Institutes of Health (NIH) in the United States. Here, he deepened his expertise in virology and molecular biology, particularly in understanding the mechanisms of viral infections in yeast. Upon returning to Spain, Dr. Ribas continued his career trajectory at the IMB as an Assistant Professor under the LRU scheme and subsequently secured positions as a postdoctoral researcher and later as a Research Scientist under various contracts and grants. His research during these years focused on yeast genetics, cell biology, and the development of novel antifungal strategies based on cell wall synthesis inhibition.

Honors and Awards:

Dr. Juan Carlos Ribas Elcorobarrutia has garnered several honors and awards throughout his illustrious career in microbiology and functional genomics. His notable achievements reflect his significant contributions to scientific research and leadership in the field. Dr. Ribas was recognized early in his academic journey with the prestigious Extraordinary Doctorate Award from the University of Salamanca in 1990, underscoring his outstanding doctoral research contributions. His excellence in research was further acknowledged by the CSIC, where he received the CSIC Award in 2015, highlighting his impact and leadership within the scientific community. In addition to these formal accolades, Dr. Ribas has been the recipient of multiple grants and fellowships that have supported his research endeavors, including predoctoral and postdoctoral awards from institutions such as the Spanish Ministry of Education and the NIH in the United States. These grants not only facilitated his research on yeast virology and cell wall synthesis but also enabled him to foster international collaborations and expand the frontiers of scientific knowledge. Dr. Ribas’s honors and awards underscore his dedication to advancing microbiological research and his commitment to excellence in scientific inquiry. His contributions continue to be recognized both nationally and internationally, solidifying his reputation as a leader in the field of functional genomics and microbiology.

Research Interest:

Dr. Juan Carlos Ribas Elcorobarrutia has made significant contributions to the field of microbiology and functional genomics through his pioneering research endeavors. His research focuses primarily on yeast biology, with particular emphasis on cell wall synthesis, β-glucan metabolism, and antifungal resistance mechanisms. Throughout his career, Dr. Ribas has explored fundamental aspects of yeast morphogenesis, cytokinesis, septation, and cell division, shedding light on critical processes that govern yeast cell integrity and growth. A prominent area of Dr. Ribas’s research involves the development of regulatable autolytic yeast strains for the expression of heterologous proteins, offering innovative solutions in biotechnological applications. His studies on the molecular mechanisms underlying β-glucan synthesis and its regulation have contributed significantly to our understanding of fungal cell wall dynamics and have implications for antifungal drug development.

📚Publications :

In vitro antifungal evaluation and structure–activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers …

Authors: SN Lopez, MV Castelli, SA Zacchino, JN Domınguez, G Lobo, …

Citations: 438

Year: 2001

Isolation and characterization of Saccharomyces cerevisiae mutants resistant to Calcofluor white

Authors: C Roncero, MH Valdivieso, JC Ribas, A Duran

Citations: 192

Year: 1988

In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers

Authors: MV Castelli, VV Kouznetsov, SN López, M Sortino, RD Enriz, JC Ribas, …

Citations: 178

Year: 2003

Localization of the (1, 3) β-D-glucan synthase catalytic subunit homologue Bgs1p/Cps1p from fission yeast suggests that it is involved in septation, polarized growth, mating …

Authors: JCG Cortés, J Ishiguro, A Durán, JC Ribas

Citations: 172

Year: 2002

The novel fission yeast (1, 3) β-D-glucan synthase catalytic subunit Bgs4p is essential during both cytokinesis and polarized growth

Authors: JCG Cortés, E Carnero, J Ishiguro, Y Sánchez, A Durán, JC Ribas

Citations: 164

Year: 2005

Decoying the Cap2 mRNA Degradation System by a Double-Stranded RNA Virus and Poly(A)2 mRNA Surveillance by a Yeast Antiviral System

Authors: DC Masison, A Blanc, JC Ribas, K Carroll, N Sonenberg, RB Wickner

Citations: 163

Year: 1995

cps1+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B

Authors: J Ishiguro, A Saitou, A Duran, JC Ribas

Citations: 146

Year: 1997

The (1,3)β‐d‐glucan synthase subunit Bgs1p is responsible for the fission yeast primary septum formation

Authors: JCG Cortés, M Konomi, IM Martins, J Muñoz, MB Moreno, M Osumi, …

Citations: 137

Year: 2007

Inhibitors of the fungal cell wall. Synthesis of 4-aryl-4-N-arylamine-1-butenes and related compounds with inhibitory activities on β (1–3) glucan and chitin synthases

Authors: JM Urbina, JCG Cortés, A Palma, SN López, SA Zacchino, RD Enriz, …

Citations: 132

Year: 2000

The fungal cell wall as a target for the development of new antifungal therapies

Authors: JCG Cortés, MÁ Curto, VSD Carvalho, P Pérez, JC Ribas

Citations: 116

Year: 2019